Retraction Note to: Cell Death and Disease 10.1038/s41419-020-2444-x, published online 23 April 2020
The Editors-in-Chief have retracted this article. After publication, concerns were raised regarding high similarity between the images presented in this article and a number of other articles on non-coding RNAs [1–5]. The Editors-in-Chief therefore no longer have confidence in the presented data.
The authors have not responded to any correspondence from the editor or publisher about this retraction.
References
- 1.Liu Q, Song Y, Duan X, Chang Y, Guo J. MiR-92a inhibits the progress of osteosarcoma cells and increases the cisplatin sensitivity by targeting Notch1. Biomed Res Int. 2018;2018:9870693. doi: 10.1155/2018/9870693. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.He Y, Yang Y, Liao Y, Xu J, Liu L, Li C, et al. Retracted: miR-140-3p inhibits cutaneous melanoma progression by disrupting AKT/p70S6K and JNK pathways through ABHD2. Mol Ther Oncolytics. 2020;17:83–93. doi: 10.1016/j.omto.2020.03.009. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- 3.Niu J-T, Zhang L-J, Huang Y-W, Li C, Jiang N, Niu Y-J. MiR-154 inhibits the growth of laryngeal squamous cell carcinoma by targeting GALNT7. Biochem Cell Biol. 2018;96:752–60. doi: 10.1139/bcb-2018-0047. [DOI] [PubMed] [Google Scholar]
- 4.Wu G, Li Z, Jiang P, Zhang X, Xu Y, Chen K, et al. MicroRNA-23a promotes pancreatic cancer metastasis by targeting epithelial splicing regulator protein 1. Oncotarget. 2017;8:82854–71. doi: 10.18632/oncotarget.20692. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Xu X, Zhou X, Chen Z, Gao C, Zhao L, Cui Y. Silencing of lncRNA XIST inhibits non-small cell lung cancer growth and promotes chemosensitivity to cisplatin. Aging. 2020;12:4711. doi: 10.18632/aging.102673. [DOI] [PMC free article] [PubMed] [Google Scholar]